What is Gyre Therapeutics, Inc.'s deferred income?

Gyre Therapeutics, Inc. (GYRE) reported deferred income of $840K in Q1 2026.

How has Gyre Therapeutics, Inc.'s deferred income changed year-over-year?

Gyre Therapeutics, Inc.'s deferred income decreased by 7.2% year-over-year, from $905K to $840K.

What is the long-term trend for Gyre Therapeutics, Inc.'s deferred income?

Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s deferred income has grown at a 93.3% compound annual growth rate (CAGR), from $118K to $852K.

Gyre Therapeutics, Inc. GYRE Deferred income

Deferred income at other companies

MPLXMPLX

$115M-63.7%

Arthur J. GallagherAJG

$177M+167%

Arteris, Inc.AIP

$6.16M-16.1%

Williams CompaniesWMB

$170M+6.9%

UnitedHealth GroupUNH

$3.42B+3.7%

Lantheus HoldingsLNTH

$6.6M—

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s deferred income?: Gyre Therapeutics, Inc. (GYRE) reported deferred income of $840K in Q1 2026.
How has Gyre Therapeutics, Inc.'s deferred income changed year-over-year?: Gyre Therapeutics, Inc.'s deferred income decreased by 7.2% year-over-year, from $905K to $840K.
What is the long-term trend for Gyre Therapeutics, Inc.'s deferred income?: Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s deferred income has grown at a 93.3% compound annual growth rate (CAGR), from $118K to $852K.